Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. Here you will find a continued update of Cochrane’s activities in response to the coronavirus (COVID-19) pandemic.
For more information, visit the Cochrane Website
- 7 Special Collections
- 17 New and updated Cochrane Reviews
- COVID-19 Study Register of primary research studies
Updated 23 September 2020
Cochrane publishes or updates three rapid reviews of the evidence on measures that aim to prevent potentially infected people from transmitting the virus to healthy people:
- Quarantaine, update of the review - Quarantine alone or in combination with other public health measures to control COVID‐19
- Travel-related control measures (such as border closures, partial travel restrictions and entry/exit screening) - Travel‐related control measures to contain the COVID‐19 pandemic
- Universal screening of people not seeking care for symptoms (either the general population or a targeted population based on their occupation (for example healthcare workers in hospitals) - Universal screening for SARS‐CoV‐2 infection: a rapid review
The rapid review - Oxygen targets in the intensive care unit during mechanical ventilation for acute respiratory distress syndrome - was published. This review has also been added to the Special Collection Coronavirus (COVID-19): evidence relevant to critical care. Read the Plain Language Summary and the Full Review in the Cochrane Library.
The Diagnostic Test Accuracy Review - Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 has been published. The review is already being updated. Read the Plain Language Summary and the Full Review.
A COVID-19 rapid review has been published - Digital contact tracing technologies in epidemics - Read the Plain Language Summary and the Full Review
A podcast with the lead author of the review - Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19 - was published. Listen to the podcast and read the Full Review.
An update for the review Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19. Originally published May 15, this is the first update to this Living review.
A new Cochrane Review : Diagnostic Test Accuracy review Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 disease was published. Read the Plain Language Summary or the Clinical Answer.
A new Cochrane COVID-19 Rapid Review: Antibody tests for identification of current and past infection withSARS-CoV-2. This diagnostic test accuracy review shows that antibody tests could have a useful role in detecting if someone has had COVID-19, but that timing is important
8 new Cochrane Clinical Answers were published, related to the Special Collection on optimizing health in the home workplace. Read the Cochrane Clinical Answers related to COVID-19 here.
COVID-19 Special Collection Translation: All Special Collection translations are now published in the Cochrane Library and are available in at least eight, and up to twelve, languages.
A new Cochrane Rapid Review
Video calls for reducing social isolation and loneliness in older people
A new Special Cochrane Collection
Optimizing health in the home workspace
has been published. This special collection brings together Cochrane Reviews summarizing evidence for health and wellbeing when working from home
A new „Living“ Cochrane Review
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19
was published. It is very uncertain whether plasma from people who have recovered from COVID‐19 is an effective treatment for people with COVID‐19. Several studies are still ongoing.
A new Cochrane Special Collection
Coronavirus (COVID-19) -Remote care through telehealth has been published. This Special Collection includes Cochrane Reviews that address using telehealth to support clinical management of various conditions, including asthma, diabetes, cardiovascular disease, dementia, reproductive health, and skin cancer. It includes reviews of using telehealth to provide carer and parent support as well as empowering patient self-management of their long-term conditions.
Cochrane Chief Executive Officer Mark Wilson announced the cancellation of the
27. Cochrane Colloquium Toronto
scheduled for October 4-7, 2020 because of the continued spread and impact of COVID-19 (Coronavirus) across the world.
A new Cochrane Rapid Review
Hand cleaning with ash for reducing the spread of viral and bacterial infections
A new Special Collection
Regional anaesthesia to reduce drug use in anaesthesia and avoid aerosol generation
Fast Tracked Update of the Cochrane Review
Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff
A new Cochrane Rapid Review
Quarantine alone or in combination with other public health measures to control COVID-19
Cochrane published a COVID-19 Study Register. Cochrane's COVID-19 is a freely-available, continually-updated, annotated reference collection of human studies on COVID-19, including interventional, observational, diagnostic, prognostic, epidemiological, qualitative and economic designs.
More information about the Study Register
Go to the Cochrane COVID-19 Study Register
A new Special Collection Coronavirus (COVID-19)
Effective options for quitting smoking during COVID-19
A second Cochrane Special Collection on Coronavirus (COVID-19) was published:
Infection control and prevention measures
The first Cochrane Special Collection on Coronavirus (COVID-19) was published:
Evidence relevant to critical care